GlassScriptPhysician profile
Ryan William Margolin
NPI 1811567175
$427.46
in general payments reported to CMS, 2019-2025
10 companies · $427 in 2025
The $427 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $110.94 | 2025 | |
| Glaxosmithkline, LLC. | $76.35 | 2025 | Jemperli, Zejula |
| Biotissue Holdings INC. | $52.56 | 2025 | |
| Caris Mpi, INC. | $46.24 | 2025 | Mi Cancer Seek |
| Merck Sharp & Dohme LLC | $38.53 | 2025 | Lynparza |
| Heron Therapeutics, INC. | $30.81 | 2025 | Zynrelef |
| Daiichi Sankyo INC. | $19.01 | 2025 | Injectafer |
| Organon LLC | $18.60 | 2025 | Jada System |
| Innovation Technologies INC | $17.96 | 2025 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $16.46 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Margolin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.